Related references
Note: Only part of the references are listed.Treatment of portal hypertension in patients with HCC in the era of Baveno VII
Dominique Thabut et al.
JOURNAL OF HEPATOLOGY (2023)
Liver resection after Transjugular Portosystemic Stent Shunt (TIPSS)
Svenja Sliwinski et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2023)
Safety and effectiveness of transjugular intrahepatic portosystemic shunt in hepatocellular carcinoma patients with portal hypertension: a systematic review and meta-analysis
Z. -x. Chen et al.
CLINICAL RADIOLOGY (2023)
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer-Term Follow-Up From the Phase 3 KEYNOTE-240 Trial
Philippe Merle et al.
LIVER CANCER (2023)
Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study
Wenzhe Fan et al.
EUROPEAN RADIOLOGY (2023)
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
Ann-Lii Cheng et al.
JOURNAL OF HEPATOLOGY (2022)
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
Thomas Yau et al.
LANCET ONCOLOGY (2022)
TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience
Huzheng Yan et al.
CANCER IMAGING (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
TIPS for patients with early HCC: A bridge to liver transplantation
Edouard Larrey et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)
Impact and outcomes of liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
Sergio Cortese et al.
CIRUGIA Y CIRUJANOS (2022)
TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension
Zhenkang Qiu et al.
EUROPEAN RADIOLOGY (2022)
Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Creation
Andrew C. Gordon et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2021)
Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
Wenzhe Fan et al.
EUROPEAN RADIOLOGY (2021)
Transjugular Intrahepatic Portosystemic Shunt Creation for the Prevention of Gastric Variceal Rebleeding in Patients with Hepatocellular Carcinoma: A Multicenter Retrospective Study
Jiaywei Tsauo et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2021)
Portal hypertension and hepatocellular carcinoma: Des liaisons dangereuses horizontal ellipsis
Manon Allaire et al.
LIVER INTERNATIONAL (2021)
Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt
Hai-lin Lu et al.
ABDOMINAL RADIOLOGY (2021)
Effect of transjugular intrahepatic portosystemic shunt on transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
Xi Chen et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2021)
International trends in hepatocellular carcinoma incidence, 1978-2012
Jessica L. Petrick et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes
Francesco Vizzutti et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
Comparative Analysis of Safety and Efficacy of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma in Patients with and without Pre-Existing Transjugular Intrahepatic Portosystemic Shunts
David M. Ruohoniemi et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimation
Ahmed Gabr et al.
JOURNAL OF HEPATOLOGY (2020)
Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites
Huzheng Yan et al.
TRANSLATIONAL ONCOLOGY (2020)
Original Study: Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhotic Patients
N. Tabchouri et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2019)
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment
Kazuo Tarao et al.
CANCER MEDICINE (2019)
Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension
N. Takemura et al.
BRITISH JOURNAL OF SURGERY (2019)
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery
Enric Reverter et al.
JOURNAL OF HEPATOLOGY (2019)
Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
Shi-Hua Luo et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection
Giovanni Marasco et al.
JOURNAL OF HEPATOLOGY (2019)
TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-analysis
Bin Chen et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2019)
Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study
Nadim Fares et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Transjugular intrahepatic portosystemic shunt as a bridge to non-hepatic surgery in cirrhotic patients with severe portal hypertension: a systematic review
Eylon Lahat et al.
HPB (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Transjugular intrahepatic portosystemic shunt creation for portal hypertension in patients with hepatocellular carcinoma: A systematic review
He Zhao et al.
INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION (2018)
Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites
Christophe Bureau et al.
GASTROENTEROLOGY (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
Quality Improvement Guidelines for Transjugular lntrahepatic Portosystemic Shunts
Sean R. Dariushnia et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Longitudinal Monitoring of Hepatic Blood Flow before and after TIPS by Using 4D-Flow MR Imaging
Peter Bannas et al.
RADIOLOGY (2016)
Portal Hypertension in Patients with Liver Cirrhosis: Diagnostic Accuracy of Spleen Stiffness
Yoshitaka Takuma et al.
RADIOLOGY (2016)
Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension
Bin Qiu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts
John T. Miura et al.
HPB (2015)
Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma
D. Bettinger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Repeated transcatheter arterial chemoembolization is safe for hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt
Zhu Wang et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2014)
Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: A retrospective case-control study
Adriano De Santis et al.
DIGESTIVE AND LIVER DISEASE (2014)
Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis
Lei Liu et al.
HEPATOLOGY RESEARCH (2014)
The Association Between Metabolic Syndrome and Hepatocellular Carcinoma Systemic Review and Meta-analysis
Raxitkumar Jinjuvadia et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: An updated meta-analysis
Ming Bai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Transjugular Intrahepatic Portosystemic Shunt before and after Liver Transplantation
Wael E. Saad
SEMINARS IN INTERVENTIONAL RADIOLOGY (2014)
Efficacy of TACE in TIPS Patients: Comparison of Treatment Response to Chemoembolization for Hepatocellular Carcinoma in Patients With and Without a Transjugular Intrahepatic Portosystemic Shunt
Yuo-Chen Kuo et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatotoxicity after Transarterial Chemoembolization and Transjugular Intrahepatic Portosystemic Shunt: Do Two Rights Make a Wrong?
Maureen P. Kohi et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt
Ji-Won Kang et al.
ACTA RADIOLOGICA (2012)
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis
E. Boleslawski et al.
BRITISH JOURNAL OF SURGERY (2012)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Liver Resection Associated With Mini Porto-Caval Shunt as Salvage Treatment in Patients With Progression of Hepatocellular Carcinoma Before Liver Transplantation: A Case Report
M. Polacco et al.
TRANSPLANTATION PROCEEDINGS (2010)
Transjugular intrahepatic portosystemic shunt before hepatic surgery in a patient with cirrhosis and portal hypertension: Case report
M. Chalret Du Rieu et al.
JOURNAL DE CHIRURGIE (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma
R Bañares et al.
HEPATOLOGY (2005)
Are TIPS stent-grafts a contraindication for future liver transplantation?
G Maleux et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2004)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Transjugular intrahepatic portosystemic shunts through hepatic neoplasms
M Wallace et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2003)
Long-term observation after transjugular intrahepatic portosystemic stent-shunt in two patients with hepatocellular carcinoma
J Tazawa et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
Share Paper
